Which medication is a combination of Glycopyrrolate and Formoterol?

The combination of Glycopyrrolate and Formoterol is found in Bevespi Aerosphere. This medication is designed for the management of chronic obstructive pulmonary disease (COPD) and combines a long-acting muscarinic antagonist (LAMA), Glycopyrrolate, with a long-acting beta-agonist (LABA), Formoterol. The combination works synergistically to help relax and open the airways, leading to improved breathing.

Bevespi Aerosphere provides a dual mechanism of action that can lead to improved lung function and symptom relief for patients with COPD. Glycopyrrolate primarily helps reduce bronchoconstriction, while Formoterol aids in maintaining open airways over an extended period.

Other medications listed do not reflect this specific combination. Anoro Ellipta contains Umeclidinium (a LAMA) and Vilanterol (a LABA), while Duaklir Pressair combines Aclidinium (a LAMA) with Formoterol (a LABA). Symbicort HFA features Budesonide (a corticosteroid) and Formoterol (a LABA) but does not include a muscarinic antagonist like Glycopyrrolate. Therefore, the identified combination